aml regimens - comment on existing regimen Please complete this form and submit your comments or amendments Your Details: Your Name: Your Email:   Regimen Details: AML Regimen: Choose One ADE 10 + 3 + 5 ( v1.0 - Haematology - AML - Relapse treatment) ADE 10 + 3 + 5/ Gemtuzumab ( v1.0 - Haematology - AML - Relapse treatment) ADE 8 + 3 + 5 ( v1.0 - Haematology - AML - Relapse treatment) AML 15 HD Cytarabine (1.5g/mē) ( v1.0 - Haematology - AML - Primary treatment) AML 15 HD Cytarabine (3g/mē) ( v1.0 - Haematology - AML - Primary treatment) Arsenic Trioxide - Consolidation ( v1.0 - Haematology - APL - Relapse treatment) Arsenic Trioxide - Induction ( v1.0 - Haematology - APL - Relapse treatment) DA 3 + 10 ( v1.0 - Haematology - AML - Primary treatment) DA 3 + 8 ( v1.0 - Haematology - AML - Primary treatment) Low Dose Cytararabine ( v1.0 - Haematology - AML - Primary treatment) MACE ( v1.0 - Haematology - AML - Primary treatment) MidAC ( v1.0 - Haematology - AML - Primary treatment) Spanish Treatment - Course 1 ( v1.0 - Haematology - APL - Primary treatment) Spanish Treatment - Course 2 ( v1.0 - Haematology - APL - Primary treatment) Spanish Treatment - Course 3 ( v1.0 - Haematology - APL - Primary treatment) Spanish Treatment - Course 4 ( v1.0 - Haematology - APL - Primary treatment) Spanish Treatment - Maintenance (Months 1-3) ( v1.0 - Haematology - APL - Primary treatment) Spanish Treatment - Maintenance (Months 4-24) ( v1.0 - Haematology - APL - Primary treatment) UKALL 2003 - Regimen B: Delayed Intensification I Phase IV (Part 2) ( v1.0 - Haematology - AML - Relapse treatment) Comments:

	Chemotherapy
	Haematology regimens
	AML regimens